The roots of the alpine Rhodiola (Crassulaceae) plant, Rhodiolae Radix, have been widely used as a hemostatic, antibechic, tonic, and endermic liniment for burns and contusions in traditional Chinese medicine. Chemical and biological studies on several Rhodiola plants have been reported. [2] [3] [4] [5] For example, the methanolic extract from the roots of R. sachalinensis was reported to show inhibitory activity on prolyl endopeptidase. 4) During the course of our serial studies on the bioactive constituents from Chinese natural medicines, 1, [6] [7] [8] [9] [10] [11] [12] [13] we have characterized the structures of several monoterpene oligoglycosides and cyanogenic glycosides from the roots of R. quadrifida (PALL.) FISCH. et MAY and R. sacra (PRAIN ex HAMET) S. H. FU.
For example, the methanolic extract from the roots of R. sachalinensis was reported to show inhibitory activity on prolyl endopeptidase. 4) During the course of our serial studies on the bioactive constituents from Chinese natural medicines, 1, [6] [7] [8] [9] [10] [11] [12] [13] we have characterized the structures of several monoterpene oligoglycosides and cyanogenic glycosides from the roots of R. quadrifida (PALL.) FISCH. et MAY and R. sacra (PRAIN ex HAMET) S. H. FU. 14, 15) Among the isolated constituents, monoterpene oligoglycosides, sacranosides A and B, were found to inhibit histamine release from rat exudate cells induced by an antigen-antibody reaction. 15) As a continuing study on the bioactive constituents of Rhodiolae Radix, the methanolic extract from the roots of R. sachalinensis A. BOR. was found to show a protective effect on Dgalactosamine (D-GalN)-induced cytotoxicity in primary cultured mouse hepatocytes. From the methanolic extract, we have isolated two new monoterpene glycosides, sachalosides I and II, two new flavonol bisdesmosides, sachalosides III and IV, a new cyanogenic glycoside, sachaloside V, together with 34 known compounds. Furthermore, we examined the protective effects of principal constituents on D-GalN-induced cytotoxicity in primary cultured mouse hepatocytes. In this paper, we describe the isolation and structure elucidation of the new constituents (1) (2) (3) (4) (5) and the hepatoprotective effects of principal constituents from the roots of R. sachalinensis.
The roots of R. sachalinensis were extracted with methanol under reflux. The methanolic extract (14.6% from the roots) was partitioned into an EtOAc-H 2 O mixture to furnish an EtOAc-soluble fraction (3.5%) and aqueous layer. The aqueous layer was further extracted with n-BuOH to give n-BuOH and H 2 O-soluble fractions (4.4% and 6.5%, respectively). As shown in Table 1 , the methanolic extract and the EtOAc-and n-BuOH-soluble fractions were found to show hepatoprotective effects, but the H 2 O-soluble fractions showed weak effect. The EtOAc-soluble fraction was subjected to normal-phase and reversed-phase column chromatographies, and finally HPLC to give 13 known compounds, geranyl b-D-glucopyranoside (6, 0.0070%), 16) myrtenyl 10-O-b-D-glucopyranoside (9, 0.0054%), 15) p-tyrosol (17, 0.062%), 17) 3-phenylpropyl b-D-glucopyranoside (21, 0.052%), 18) trans-cinnamyl alcohol (22, 0.0065%), 19) pcoumaric acid (26, 0.017%), 20) trans-caffeic acid (27, 0.0011%), 21) p-hydroxyphenethyl anisate (30, 0.0003%), 22) eriodictyol (32, 0.019%), 23) luteolin (33, 0.0011%), 24) kaempferol (34, 0.023%), 25) tricin (37, 0.0069%), 26) 1-octylb-D-glucopyranoside (38, 0.0019%).
18) The n-BuOH-soluble fraction was also subjected to Diaion HP-20 column chromatography (H 2 O→MeOH) to give the water-and methanoleluted fractions (0.8% and 3.5%, respectively). The methanol-eluted fraction was subjected to normal-and reversed-phase column chromatographies, and finally HPLC to give sachalosides I (1, 0.0004%), II (2, 0.0005%), III (3, 0.0003%), IV (4, 0.0004%), and V (5, 0.0007%), together with 21 known compounds, geranyl 1-O-a-L-arabinofuranosyl(1→6)-b-D-glucopyranoside (7, 0.0029%), 27) kenposide A (8, 0.0028%), 28) sacranoside A (10, 0.0011%), 15) rhodiocyanoside A (11, 0.23%), 14) lotaustralin (12, 0.0014%), 29) hetorodendrin (13, 0.0002%), 30) benzyl b-D-glucopyranoside (14, 0.0022%), 31) 34) salidroside (19, 0.10%), 35) 2-(4-methoxyphenyl)-ethyl b-D-glucopyranoside (20, 0.0004%), 36) trans-cinnamyl b-D-glucopyranoside (23, 0.0046%), 37) rosarin (24, 0.0097%), 38) rosavin (27, 0.034%), 39) 40) gein (29, 0.0007%), 41) nodakenin (31, 0.0021%), 42) leucoside (35, 0.0028%), 32) rhodiosin (36, 0.014%), 43) 1-octyl-a-D-arabinofuranosyl(1→6)-b-D-glucopyranoside (39, 0.0009%).
44)
Bioactive Constituents from Chinese Natural Medicines. XXVI. C-NMR spectra of 1 were similar to those of sacranoside A (10), 15) whereas the proton and carbon signals due to the monoterpene part were superimposable on those of L-cis-myrtanol-b -D-glucopyranoside.
47) The aglycon part of 1 was identified to be cis-myrtanol from the following physicochemical evidence. As shown in Fig. 1 , the double quantum filter correlation spectroscopy (DQF COSY) experiment on 1 indicated the presence of partial structures written in bold lines, and in the heteronuclear multiple-bond correlations (HMBC) experiment, long-range correlations were observed between the following protons and carbons: H-1 and C-7, 10; H-2 and C-6, 7, 10; H 2 -3 and C-4, 5, 10; H-5 and C-3, 4, 7; H 2 -7 and C-1, 5, 6; H 3 -8 and C-1, 5, 6, 9; H 3 -9 and C-1, 5, 6, 8; H 2 -10 and C-1, 2, 3, 1Ј; H-1Ј and C-10. C-NMR spectra of 2 were similar to those of sacranoside A (10) 15) and sachaloside I (1), while the signals due to the monoterpene part resembled those of trans-pinocarveol. 48) As shown in Fig. 1 , long-range correlations in the HMBC experiment on 2 were observed between the following proton and carbon: H-1 and C-3, 7, 10; H-3 and C-1, 10, 1Ј; H 2 -4 and C-2, 3, 5, 7; H-5 and C-1, 6, 8, 9; H 2 -7 and C-1, 5; H 3 -8 and C-1, 6, 9; H 3 -9 and C-1, 6, 8; H 2 -10 and C-1, 3; H-1Ј and C-3, so that the planar structure of the monoterpene part and the diglycoside structure were clarified. The relative stereostructure of the monoterpene part in 2 was characterized by NOESY experiment, which showed NOE correlation between the following proton pairs: H-1 and H-7b, H 3 -9; H-3b and H-4b, H 3 -8; H-5 and H-4a, H-7b, H 3 -9; H-7b and H 3 -9. On the basis of this evidence, the structure of sachaloside II was determined as shown. Sachaloside III (3) C-NMR spectra of 3 were similar to those of kaempferol 3,7-di-O-a-L-rhamnopyranoside, 49) while the proton and carbon signals due to the 3-O-glycoside moiety was similar to those of leucoside (35) . 32) Furthermore, the structure of 3 was characterized by means of DQF COSY and HMBC experiments (Fig. 1) . Long-range correlations in the HMBC experiment on 3 were observed between the following proton and carbon: H-1Љ and C-3; H-1ٞ and C-2Љ; H-1ЉЉ and C-7. On the basis of the above-mentioned evidence, the structure of sachaloside III was determined to be kaempferol
Sachaloside IV (4) was obtained as a yellow amorphous powder with a negative optical rotation ( (Table 1) spectra of 4, which were assigned by various NMR experiments, 46) showed signals assignable to a flavonol moiety [ 50) The 8-hydroxykaempferol 3,7-diglycoside structure of 4 was characterized by means of DQF COSY and HMBC experiments, which showed long-range correlations between the following proton and carbon: H-1Љ and C-3; H-1ٞ and C-7; H-1ЉЉ and C-3ٞ (Fig. 1) . On the basis of the above-mentioned evidence, the structure of sachaloside IV was determined to be 8- C-NMR spectra were similar to those of lotaustralin (12), 29) except for the signals due to the hydroxymethyl moiety in 5. The structure of 5 was characterized by means of DQF COSY and HMBC experiments (Fig. 1) . That is, long-range correlations in the HMBC experiment on 5 were observed between the following proton and carbon: H-3 and C-1, 2, 5; H-4 and C-2; H-5 and C-1, 2, 3; H-1Ј and C-2. On the basis of this evidence, the structure of sachaloside V was determined as shown. 51) Previously, we have reported the isolation and structure elucidation of several constituents with hepatoprotective effects from Chinese natural medicines, Bupleurum scorzonerifolium, 52, 53) Panax notoginseng, 54) and Sedum sarmentosum. 1) Since the methanolic extract from the roots of R. sachalinensis was found to show protective effects on DGalN-induced cytotoxicity in primary cultured mouse hepatocytes, the activities of the major isolated constituents were examined. As shown in Table 3 , sachaloside III (3), sachaloside IV (4), trans-caffeic acid (27) , and rhodiosin (36) were found to show the hepatoprotective effects. The effects of 3 and 4 were equivalent to that of the hepatoprotective agent silybin, 55) and the effect of 36 was equivalent to that of eriodictyol (32), which was already known to display hepatoprotective effect. 56) On the other hand, the effects of 27 were stronger than those of p-coumaric acid (26) and p-tyrosol (17) . These results suggested that the pyrocatechol moiety of 27 was essential to exerting the effect. Monoterpenes, 6 and 9, and cyanogenic glycosides, 12 and 13, were found to lack the activities.
Experimental General Experimental Procedures
The following instruments were used to obtain physical data: specific rotations, Horiba SEPA-300 digital polarimeter (lϭ5 cm); IR spectra, Shimadzu FTIR-8100 spectrometer; EI-MS and HR-EI-MS, JEOL JMS-GCMATE mass spectrometer; FAB-MS and HR-FAB-MS, JEOL JMS-SX 102A mass spectrometer; 1 H-NMR spectra, JEOL EX-270 (270 MHz), JNM-LA500 (500 MHz), and JEOL ECA-600K (600 MHz) spectrometers; Extraction and Isolation The dried roots of R. sachalinensis (10.0 kg) were powdered and extracted 3 times with methanol under reflux for 3 h. Evaporation of the solvent under reduced pressure provided a methanolic extract (1457 g, 14.6% from the dried roots), and an aliquot (1395 g) was partitioned into an EtOAc-H 2 O (1 : 1, v/v) mixture to furnish an EtOAc-soluble fraction (336 g, 3.5%) and an aqueous phase. The aqueous phase was further extracted with n-BuOH to give an n-BuOH-soluble fraction (418 g, 4.4%) and an H 2 O-soluble fraction (620 g, 6.5%). The EtOAc fraction (139 g) was subjected to ordinary-phase silica gel column chromatography 
